Impower 030

A Phase III, double-blinded, multicenter, randomized study evaluating the efficacy and safety of neoadjuvant treatment with Atezolizumab or placebo in combination with Platinum-based chemotherapy in patients with resectable stage II, IIIa, or select IIIb Non−Small Cell Lung Cancer.



Pius-Hospital Oldenburg

Georgstraße 12
26121 Oldenburg

Tel: 0441 / 229 0
Fax: 0441 / 229 1607

Professor Dr. med. Frank Griesinger
Pius-Hospital Oldenburg
Klinik für Hämatologie und Onkologie
Universitätsklinik Innere Medizin-Onkologie
Medizinischer Campus Universität Oldenburg

Vorherige Studie
Nächste Studie
to top icon